Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma

Suppressor of cytokine signalling (SOCS) 1/2/3/4 are involved in the occurrence and progression of multiple malignancies; however, their prognostic and developmental value in patients with glioblastoma (GBM) remains unclear. The present study used TCGA, ONCOMINE, SangerBox3.0, UALCAN, TIMER2.0, GENE...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lirui, Han, Yongjie, Yang, Zhuo, Zeng, Yuling, Liang, Wulong, Shi, Zimin, Tao, Yiran, Liang, Xianyin, Liu, Wanqing, Zhou, Shaolong, Xing, Zhe, Hu, Weihua, Wang, Xinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399539/
https://www.ncbi.nlm.nih.gov/pubmed/37315184
http://dx.doi.org/10.1111/jcmm.17807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399539/
https://www.ncbi.nlm.nih.gov/pubmed/37315184
http://dx.doi.org/10.1111/jcmm.17807

Ejemplares similares